The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese Blood and Marrow Transplant Registry group

Haematologica. 2024 Jun 1;109(6):2000-2004. doi: 10.3324/haematol.2023.284581.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anemia, Aplastic* / diagnosis
  • Anemia, Aplastic* / mortality
  • Anemia, Aplastic* / therapy
  • China / epidemiology
  • East Asian People
  • Female
  • Hematopoietic Stem Cell Transplantation* / methods
  • Humans
  • Male
  • Middle Aged
  • Registries*
  • Transplantation, Homologous*
  • Treatment Outcome

Grants and funding

Funding: This work was supported by National Key Research and Development Program of China (n. 2022YFA1103300), Major Program of the National Natural Science Foundation of China (n. 82293630), Key Program of the National Natural Science Foundation of China (n. 81930004), the National Natural Science Foundation of China (n. 82100227 & 81873446), the National High Technology Research and Development Program of China (n. 2021YFA1101504), and the Key Research and Development Program of Hubei Province (n. 2022BCA017).